256 - The New FDA Inspection Playbook: Where to Start with QMSR

Let's Combinate · 28 Sept 2026 · 9m

What this episode covers

Subhi Saadeh, founder of Let’s Combinate, introduces a four-part series on FDA inspection readiness under the new Quality Management System Regulation (QMSR), explaining how the retired QSIT framework has been replaced by Compliance Program 7382.850. He highlights advice from former FDA investigator Eric Pittman, who advises industry to focus exclusively on Section III of compliance programs as the primary roadmap for inspections. The episode details the shift from QSIT’s four major subsystems to six QMS areas, emphasizing a risk-based approach where investigators evaluate product risks and control effectiveness.

Most relevant to

large enterprises

Topics

Mentioned

Companies
FDA, Let’s Combinate
Also
QMSR, QSIT, ISO 13485, Compliance Program 7382.850

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 33m

    #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls

    Nikhil Mangale, Vice President of Quality at Kapstone Medical, discusses the real-world impact of the FDA's Quality Management System Regulation (QMSR) based on seven months of inspection data. He identifies the top five FDA citations as risk management, supplier controls, complaint handling, Unique Device Identification (UDI), and corrective actions, noting that inspectors now focus on operational processes rather than terminology updates like renaming Design History Files (DHF) to Design and Development Files (DDF). Mangale advises companies to implement a three-layer mapping strategy, prioritize risk management as a living process, and maintain open DDFs throughout the product lifecycle to avoid citations. He also clarifies that ISO 13485 certification does not exempt companies from FDA inspections and highlights the continued value of MDSAP enrollment for sites in multiple jurisdictions.

  • Global Medical Device Podcast · 19m

    #438: QMSR Mythbusters Episode

    Host Etia Nichols from Greenlight Guru explains the FDA's new Quality Management System Regulation (QMSR), which replaces 21 CFR Part 820 and incorporates ISO 13485:2016 by reference, with a mandatory enforcement date of February 2, 2026. Nichols debunks the myth that the Device Master Record (DMR), Design History File (DHF), and Device History Record (DHR) are being eliminated, clarifying they are mapped to the Medical Device File (MDF), Design and Development File (DDP), and Batch or Lot Record respectively. She highlights three critical shifts: the explicit integration of lifecycle risk management as the 'DNA' of the QMS, the loss of audit privilege making internal records inspectable, and retained US-specific requirements like UDI in complaint records and extended record retention.

  • Global Medical Device Podcast · 48m

    QMSR: The Future of FDA's Quality Management System Regulation for Medical Devices

    Mike Drues of Vascular Sciences and George Zack of Two Harbors Consulting discuss the FDA's proposed Quality Management System Regulation (QMSR) to align 21 CFR Part 820 with ISO 13485:2016. The panel argues that the transition is a small leap for compliant companies, focusing on paperwork rather than engineering changes, and questions the value of constant regulatory updates. They highlight the tension between compliance and actual product quality, noting that while harmonization is a step toward global standards, true global regulatory harmonization remains unlikely due to differing national protections.

  • Global Medical Device Podcast · 54m

    #329 The Right Way to Start a QMS: When, How, & What

    Rob MacCuspie, Manager of Regulatory and Quality Affairs at Proxima Clinical Research, explains how to build a Quality Management System (QMS) by balancing investor cost concerns with FDA regulatory requirements. He argues that a QMS is not just a document management system but a culture driven by management responsibility and people, using a 'highway vs. mountain road' analogy to describe risk-based rigor for different device classes. MacCuspie details the phased implementation of QMS components, the specific challenges of Software as a Medical Device (SaMD) regarding labeling and testing, and the operational efficiency gains of moving from paper to compliant electronic systems like Greenlight Guru.

  • Global Medical Device Podcast · 32m

    #360: Is It Possible to "Buy" a QMS?

    Sara Adams, a quality engineering expert with extensive experience in FDA inspections, explains why Quality Management Systems (QMS) cannot be bought off-the-shelf, using a sourdough bread analogy to illustrate the need for customization. She details the layers of a QMS, from procedural documents to electronic storage, emphasizing that while tools like Greenlight Guru provide 'guardrails,' the specific procedures must be tailored to the company's risk profile and regulatory requirements. Adams highlights common pitfalls, such as using non-compliant signatures in SharePoint or paper-based systems, and stresses that the ultimate goal of any QMS decision is patient safety, not just passing an audit.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.